Pre-core mutant infections in the Canadian Inuit

Journal of Hepatology

Volumn 33, Issue 5, 2000, Pages 781-784

  Minuk, Gerald Y ^a,d   Orr, Pamela S ^a   Brown, Rosemay ^b   Macdonald, Sharon ^a   Chaudhary, Rabinda K ^c   Temple, Paula ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Keewatin Regional Health Board   (Canada)

^c LAB CENTRE FOR DISEASE CONTROL   (Canada)

^d HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Aboriginal; Hepatitis; Hepatitis B; Inuit; Liver disease; Precore mutant

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ABORIGINE; ARTICLE; CANADA; DISEASE CARRIER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME;

EID: 0033759042     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80310-4     Document Type: Article

References (22)

1. Hepatitis virus infection in an isolated Canadian Inuit (Eskimo) population
2. The changing epidemiology of hepatitis B infection in the Canadian north
3. Extension of the epidemiology of hepatitis B in circumpolar regions through a comprehensive serologic study in the Northwest Territories of Canada
4. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection
5. Analysis of liver disease, nuclear HBcAg, viral replication and hepatitis B virus DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus
6. Discordance of hepatitis B e antigen/antibody and hepatitis B virus deoxyribonucleic acid in serum: Analysis of 1063 specimens
7. Precore mutant hepatitis B virus infection and liver disease
8. The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study
9. Hepatitis e antigen negative chronic hepatitis B: From clinical recognition of pathogenesis and treatment
10. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients
11. Detection of hepatitis B virus precore TAG mutant by an amplification-created restriction site method
12. Some observations on the epidemiology and transmission of hepatitis B
13. Distribution of pre-core A83 point mutation in hepatitis B virus infections
14. Interferon-alpha 2a for chronic hepatitis B with e antigen or antibody: Comparable antiviral effects on wild-type virus and precore mutant
15. The changing picture of neoplastic disease in the western and central Canadian Arctic (1950-1980)
16. The dietary content of putrescine in two populations at risk for hepatocellular carcinoma
17. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection
18. Interferon therapy for the anti-HBe positive form of chronic hepatitis B
19. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B
20. Wild-type e antigen-minus hepatitis B viruses and course of chronic hepatitis
21. Primary hepatocellular carcinoma in Alaskan natives. 1969-1979
22. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B